ELV vs HNGE vs CVS Stock Comparison

Elevance Health, Hinge Health and Cvs Health Prices as of Nov 16, 2026 Peers: Industry group
1 more company in this comparison (CRVL) Create a free account to keep reading and compare up to 10 companies.
ELV Elevance Health, Inc.
$446.47 +4.3% 1M +37.0% 1Y
Market cap
$93.96B
P/E
18.3x
Revenue (TTM)
$201.83B
Div. yield
–
Managed Care Healthcare
2 wins
HNGE Hinge Health, Inc.
$121.24 +22.2% 1M +196.0% 1Y
Market cap
$9.19B
P/E
55.1x
Revenue (TTM)
$800.82M
Div. yield
–
Telehealth Healthcare
3 wins
CVS CVS HEALTH Corp
$88.61 -4.1% 1M +13.9% 1Y
Market cap
$109.76B
P/E
9.9x
Revenue (TTM)
$420.61B
Div. yield
–
Managed Care Healthcare
6 wins

Head to Head

11 decided of 12

Cvs Health leads on 6 of the 12 questions below (Cvs Health 6, Hinge Health 3, Elevance Health 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionELVHNGECVSLeader
Larger companyMarket capitalisation $93.96B $9.19B $109.76B CVS
Cheaper on earningsLower P/E, profitable companies only 18.3x 55.1x 9.9x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 14.3x 42.9x 10.2x CVS
Faster revenue growthRevenue growth, trailing twelve months +3.6% +49.9% +6.7% HNGE
More profitableNet margin, trailing twelve months 2.5% 20.8% 2.6% HNGE
Better return on capitalReturn on invested capital 8.3% — 9.7% CVS
Less leveragedLower net debt / EBITDA -0.5x — 2.3x ELV
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +37.0% +196.0% +13.9% HNGE
Better 5-year returnAnnualised price return, 5 years +0.8%/yr — -0.9%/yr ELV
Less volatileAnnualised volatility, 1 year 35.8% 51.1% 35.2% CVS
Higher overall scoreMean of the five percentile scores vs peers 68/100 70/100 72/100 CVS

Percentile Scorecard

ELVHNGECVS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisELVHNGECVS
Valuation 81 #6 of 27 27 #73 of 99 100 #1 of 27
Growth 36 #17 of 26 97 #4 of 89 80 #6 of 26
Profitability 72 #8 of 26 99 #2 of 92 84 #5 of 26
Financial Health 68 #9 of 26 45 #57 of 103 24 #20 of 26
Shareholder Returns 82 #4 of 18 84 #11 of 63 71 #6 of 18
Overall 68 70 72
  • ELV ranked among 27 companies in Healthcare Payers and Distributors
  • HNGE ranked among 103 companies in Healthcare Providers
  • CVS ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodELVHNGECVSSPY
1 month +4.3%+22.2%-4.1% -3.0%
3 months +14.4%+37.9%-5.8% -4.2%
6 months +13.3%+121.6%-7.7% +0.2%
Year to date +27.4%+161.0%+11.7% +8.5%
1 year +37.0%+196.0%+13.9% +10.1%
3 years -3.6%—+28.8% +64.1%
3 years, per year -1.2%—+8.8% +18.0%
5 years +3.9%—-4.4% +58.1%
5 years, per year +0.8%—-0.9% +9.6%
10 years +222.6%—+18.8% +239.6%
10 years, per year +12.4%—+1.7% +13.0%

Risk

MeasureELVHNGECVSSPY
Volatility, 1Y 35.8%51.1%35.2% 13.8%
Downside volatility, 1Y 38.2%47.1%38.7% 14.2%
Beta vs S&P 500, 1Y 0.251.11-0.04 1.00
Return / volatility, 1Y 1.033.840.39 0.74
Max drawdown, 5Y -51.2%-48.5%-60.5% -25.4%
From 52-week high 0.0%-1.6%-19.8% -5.0%
52-week high $446.47$123.17$110.55 $779.14
52-week low $280.74$31.17$70.08 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleELVHNGECVS
P/E now vs peer median 18.1xmedian 25.2x 56.0xmedian 22.4x 10.4xmedian 25.2x
P/S now vs peer median 0.5xmedian 0.4x 11.7xmedian 1.3x 0.3xmedian 0.4x
EV/EBITDA now vs peer median 9.6xmedian 14.5x 40.0xmedian 14.2x 8.2xmedian 14.5x
P/FCF now vs peer median 14.3xmedian 16.5x 29.1xmedian 19.0x 7.3xmedian 16.5x
P/B now vs peer median 2.1xmedian 2.7x 31.3xmedian 2.6x 1.4xmedian 2.7x
PEG now vs peer median -7.75median 1.72 —median 0.84 1.22median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsELVHNGECVS
Revenue $201.83B $800.82M $420.61B
Gross profit $53.35B $686.54M $186.06B
Operating income $7.70B $150.09M $15.06B
Net income $5.13B $168.31M $11.09B
Free cash flow $6.51B $322.00M $15.57B
R&D – $134.62M –
EPS (diluted) $23.62 $1.93 $8.55
Cash & equivalents $10.35B $211.55M $11.74B
Total debt $30.76B – $60.68B
Shares (diluted) 217.60M 86.53M 1.29B
Enterprise value -$48.62B $7.82B $58.51B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricELVHNGECVS
P/E 18.1x 56.0x 10.4x
P/FCF 14.3x 29.1x 7.3x
P/Operating cash flow 12.2x 29.0x 6.1x
P/S 0.5x 11.7x 0.3x
P/B 2.1x 31.3x 1.4x
P/Tangible book 2.7x 40.6x 2.0x
EV/EBITDA 9.6x 40.0x 8.2x
EV/EBIT 11.4x 60.5x 10.6x
EV/Revenue 0.4x 11.3x 0.4x
EV/FCF 13.5x 28.2x 10.3x
EV/Operating cash flow 11.6x 28.1x 8.6x
PEG (3Y EPS CAGR) -7.75 – 1.22

Growth

14 metrics
MetricELVHNGECVS
Revenue growth (1Y) 3.6% 49.9% 6.7%
Revenue CAGR (3Y) 6.2% – 6.5%
Gross profit growth (1Y) 4.3% 63.4% 5.3%
Gross profit CAGR (3Y) 5.5% – 10.9%
Operating income growth (1Y) -9.2% 127.2% 206.4%
Operating income CAGR (3Y) -4.2% – 2.4%
Net income growth (1Y) -7.4% 131.6% 2,369%
Net income CAGR (3Y) -5.2% – 8.6%
EPS growth (1Y) -4.5% 135.4% 2,213%
EPS CAGR (3Y) -2.3% – 8.5%
Operating cash flow growth (1Y) 54.6% 121.4% 105.4%
Operating cash flow CAGR (3Y) -7.2% – 9.9%
Free cash flow growth (1Y) 72.9% 121.4% 147.4%
Free cash flow CAGR (3Y) -7.6% – 11.3%

Profitability

14 metrics
MetricELVHNGECVS
Gross margin 26.4% 85.7% 44.2%
EBITDA margin 4.6% 28.3% 4.7%
Operating margin 3.8% 18.7% 3.6%
Pretax margin 3.1% 20.8% 2.9%
Net margin 2.5% 20.8% 2.6%
FCF margin 3.2% 40.2% 3.7%
Operating cash flow margin 3.8% 40.3% 4.4%
Return on equity 11.4% 52.2% 13.8%
Return on assets 4.0% 19.7% 4.3%
Return on invested capital 8.3% – 9.7%
Return on capital employed 9.6% 49.0% 9.2%
Asset turnover 1.6x 0.9x 1.6x
Cash conversion (OCF / net income) 1.5x 1.9x 1.7x
Stock comp / revenue 0.1% 8.4% 0.2%

Financial Health

11 metrics
MetricELVHNGECVS
Debt / assets 24.1% – 23.5%
Debt / equity 0.7x – 0.8x
Net debt / EBITDA -0.5x – 2.3x
Debt / FCF 4.7x – 3.9x
Liabilities / assets 65.0% 65.7% 68.7%
Equity / assets 35.0% 34.3% 31.3%
Interest coverage 5.3x – 4.9x
Current ratio 1.5x 1.0x 0.9x
Quick ratio 1.2x 0.9x 0.8x
Cash ratio 0.8x 0.5x 0.2x
Altman Z-score 3.06 9.84 2.51

Shareholder Returns

7 metrics
MetricELVHNGECVS
Dividend yield 1.6% – 3.0%
Net buyback yield 2.2% 2.2% -0.4%
Shareholder yield 3.8% 2.2% 2.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusELVHNGECVS
Forward P/E 14.3xFY2026 42.9xFY2026 10.2xFY2026
EPS, next fiscal year $30.12FY2026 $2.69FY2026 $8.80FY2026
EPS growth, next FY -0.6%FY2026 +2.7%FY2026 +30.4%FY2026
EPS growth, the year after +4.2% +20.8% +1.1%
Revenue, next fiscal year $211.92BFY2026 $899.57MFY2026 $431.16BFY2026
Revenue growth, next FY +7.3%FY2026 +53.0%FY2026 +7.2%FY2026
Revenue growth, the year after +0.0% +29.5% -5.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersELVHNGECVS
Held by institutions 91.8% 92.1% 89.1%
Institutions holding 1,615 279 2,074
Change in shares held, QoQ +1.7% +2.5% +3.5%
Institutions buying 862 198 1,103
Institutions selling 542 66 733
Buyers to sellers 1.59 3.00 1.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ELVHNGECVS
ELV 1.00 0.13 0.42
HNGE 0.13 1.00 0.05
CVS 0.42 0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ELV, HNGE and CVS?

Cvs Health (CVS) is the largest by market capitalisation: Elevance Health (ELV) $93.96B, Hinge Health (HNGE) $9.19B, Cvs Health (CVS) $109.76B.

Which stock is cheaper, ELV, HNGE and CVS?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Elevance Health (ELV) 18.3x, Hinge Health (HNGE) 55.1x, Cvs Health (CVS) 9.9x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Elevance Health (ELV) 14.3x, Hinge Health (HNGE) 42.9x, Cvs Health (CVS) 10.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Hinge Health (HNGE) grew revenue fastest over the trailing twelve months: Elevance Health (ELV) +3.6%, Hinge Health (HNGE) +49.9%, Cvs Health (CVS) +6.7%.

Which company is more profitable?

Hinge Health (HNGE) has the highest net margin (Elevance Health (ELV) 2.5%, Hinge Health (HNGE) 20.8%, Cvs Health (CVS) 2.6%). On return on invested capital, Cvs Health (CVS) leads (Elevance Health (ELV) 8.3%, Cvs Health (CVS) 9.7%).

Which stock has performed better?

Over the past year Hinge Health (HNGE) returned the most: Elevance Health (ELV) +37.0%, Hinge Health (HNGE) +196.0%, Cvs Health (CVS) +13.9%. Over five years, Elevance Health (ELV) compounded fastest (Elevance Health (ELV) +0.8%/yr, Cvs Health (CVS) -0.9%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cvs Health (CVS) has been the steadiest (Elevance Health (ELV) 35.8%, Hinge Health (HNGE) 51.1%, Cvs Health (CVS) 35.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ELV, HNGE and CVS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cvs Health (CVS) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.